nodes	percent_of_prediction	percent_of_DWPC	metapath
Diatrizoate—Sneezing—Capecitabine—colon cancer	0.00866	0.00866	CcSEcCtD
Diatrizoate—Sensory loss—Vincristine—colon cancer	0.00849	0.00849	CcSEcCtD
Diatrizoate—Stinging—Fluorouracil—colon cancer	0.00847	0.00847	CcSEcCtD
Diatrizoate—Extravasation—Vincristine—colon cancer	0.00843	0.00843	CcSEcCtD
Diatrizoate—Speech disorder—Irinotecan—colon cancer	0.00833	0.00833	CcSEcCtD
Diatrizoate—Numbness—Fluorouracil—colon cancer	0.00828	0.00828	CcSEcCtD
Diatrizoate—Extravasation—Irinotecan—colon cancer	0.00821	0.00821	CcSEcCtD
Diatrizoate—Vasodilation—Irinotecan—colon cancer	0.00815	0.00815	CcSEcCtD
Diatrizoate—Vasodilation procedure—Irinotecan—colon cancer	0.00815	0.00815	CcSEcCtD
Diatrizoate—Eye irritation—Fluorouracil—colon cancer	0.00804	0.00804	CcSEcCtD
Diatrizoate—Speech disorder—Fluorouracil—colon cancer	0.00798	0.00798	CcSEcCtD
Diatrizoate—Drug interaction—Vincristine—colon cancer	0.00793	0.00793	CcSEcCtD
Diatrizoate—Sensory loss—Fluorouracil—colon cancer	0.00792	0.00792	CcSEcCtD
Diatrizoate—Extravasation—Fluorouracil—colon cancer	0.00786	0.00786	CcSEcCtD
Diatrizoate—Cough increased—Irinotecan—colon cancer	0.00783	0.00783	CcSEcCtD
Diatrizoate—Lacrimation increased—Irinotecan—colon cancer	0.00777	0.00777	CcSEcCtD
Diatrizoate—Haematoma—Capecitabine—colon cancer	0.00763	0.00763	CcSEcCtD
Diatrizoate—Respiratory distress—Capecitabine—colon cancer	0.00755	0.00755	CcSEcCtD
Diatrizoate—Nephropathy—Methotrexate—colon cancer	0.0075	0.0075	CcSEcCtD
Diatrizoate—Lacrimation increased—Fluorouracil—colon cancer	0.00745	0.00745	CcSEcCtD
Diatrizoate—Pulmonary embolism—Irinotecan—colon cancer	0.00716	0.00716	CcSEcCtD
Diatrizoate—Thrombosis—Capecitabine—colon cancer	0.00677	0.00677	CcSEcCtD
Diatrizoate—Coma—Vincristine—colon cancer	0.00672	0.00672	CcSEcCtD
Diatrizoate—Azotaemia—Methotrexate—colon cancer	0.0067	0.0067	CcSEcCtD
Diatrizoate—Coma—Fluorouracil—colon cancer	0.00627	0.00627	CcSEcCtD
Diatrizoate—Ventricular fibrillation—Capecitabine—colon cancer	0.00626	0.00626	CcSEcCtD
Diatrizoate—Thrombophlebitis—Irinotecan—colon cancer	0.00601	0.00601	CcSEcCtD
Diatrizoate—Injection site pain—Capecitabine—colon cancer	0.00587	0.00587	CcSEcCtD
Diatrizoate—Petechiae—Capecitabine—colon cancer	0.00583	0.00583	CcSEcCtD
Diatrizoate—Eruption—Methotrexate—colon cancer	0.0058	0.0058	CcSEcCtD
Diatrizoate—Thrombophlebitis—Fluorouracil—colon cancer	0.00575	0.00575	CcSEcCtD
Diatrizoate—Injury—Irinotecan—colon cancer	0.00566	0.00566	CcSEcCtD
Diatrizoate—Swelling—Fluorouracil—colon cancer	0.00565	0.00565	CcSEcCtD
Diatrizoate—Renal failure acute—Irinotecan—colon cancer	0.00563	0.00563	CcSEcCtD
Diatrizoate—Eye irritation—Capecitabine—colon cancer	0.00562	0.00562	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Irinotecan—colon cancer	0.00537	0.00537	CcSEcCtD
Diatrizoate—Amnesia—Fluorouracil—colon cancer	0.0053	0.0053	CcSEcCtD
Diatrizoate—Lacrimation increased—Capecitabine—colon cancer	0.0052	0.0052	CcSEcCtD
Diatrizoate—Paralysis—Methotrexate—colon cancer	0.00514	0.00514	CcSEcCtD
Diatrizoate—Cardiac arrest—Vincristine—colon cancer	0.00508	0.00508	CcSEcCtD
Diatrizoate—Cyanosis—Methotrexate—colon cancer	0.00504	0.00504	CcSEcCtD
Diatrizoate—Cardiac arrest—Irinotecan—colon cancer	0.00495	0.00495	CcSEcCtD
Diatrizoate—Blood creatinine increased—Irinotecan—colon cancer	0.00487	0.00487	CcSEcCtD
Diatrizoate—Pulmonary embolism—Capecitabine—colon cancer	0.0048	0.0048	CcSEcCtD
Diatrizoate—Cardiac arrest—Fluorouracil—colon cancer	0.00474	0.00474	CcSEcCtD
Diatrizoate—Cramp muscle—Irinotecan—colon cancer	0.00468	0.00468	CcSEcCtD
Diatrizoate—Skin exfoliation—Capecitabine—colon cancer	0.00458	0.00458	CcSEcCtD
Diatrizoate—Necrosis—Methotrexate—colon cancer	0.00455	0.00455	CcSEcCtD
Diatrizoate—Petechiae—Methotrexate—colon cancer	0.00434	0.00434	CcSEcCtD
Diatrizoate—Neutropenia—Vincristine—colon cancer	0.00432	0.00432	CcSEcCtD
Diatrizoate—Neutropenia—Irinotecan—colon cancer	0.0042	0.0042	CcSEcCtD
Diatrizoate—Speech disorder—Methotrexate—colon cancer	0.00415	0.00415	CcSEcCtD
Diatrizoate—Extravasation—Methotrexate—colon cancer	0.00409	0.00409	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Vincristine—colon cancer	0.00406	0.00406	CcSEcCtD
Diatrizoate—Myocardial infarction—Vincristine—colon cancer	0.00403	0.00403	CcSEcCtD
Diatrizoate—Thrombophlebitis—Capecitabine—colon cancer	0.00402	0.00402	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Irinotecan—colon cancer	0.00395	0.00395	CcSEcCtD
Diatrizoate—Swelling—Capecitabine—colon cancer	0.00395	0.00395	CcSEcCtD
Diatrizoate—Sweating—Vincristine—colon cancer	0.00395	0.00395	CcSEcCtD
Diatrizoate—Renal failure—Irinotecan—colon cancer	0.00394	0.00394	CcSEcCtD
Diatrizoate—Myocardial infarction—Irinotecan—colon cancer	0.00393	0.00393	CcSEcCtD
Diatrizoate—Oliguria—Methotrexate—colon cancer	0.00387	0.00387	CcSEcCtD
Diatrizoate—Sweating—Irinotecan—colon cancer	0.00384	0.00384	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Fluorouracil—colon cancer	0.00378	0.00378	CcSEcCtD
Diatrizoate—Renal failure acute—Capecitabine—colon cancer	0.00377	0.00377	CcSEcCtD
Diatrizoate—Myocardial infarction—Fluorouracil—colon cancer	0.00376	0.00376	CcSEcCtD
Diatrizoate—Conjunctivitis—Fluorouracil—colon cancer	0.00373	0.00373	CcSEcCtD
Diatrizoate—Amnesia—Capecitabine—colon cancer	0.0037	0.0037	CcSEcCtD
Diatrizoate—Hypoaesthesia—Vincristine—colon cancer	0.00368	0.00368	CcSEcCtD
Diatrizoate—Haemoglobin—Irinotecan—colon cancer	0.00362	0.00362	CcSEcCtD
Diatrizoate—Rhinitis—Irinotecan—colon cancer	0.00361	0.00361	CcSEcCtD
Diatrizoate—Haemorrhage—Irinotecan—colon cancer	0.0036	0.0036	CcSEcCtD
Diatrizoate—Pulmonary embolism—Methotrexate—colon cancer	0.00357	0.00357	CcSEcCtD
Diatrizoate—Haemoglobin—Fluorouracil—colon cancer	0.00346	0.00346	CcSEcCtD
Diatrizoate—Rhinitis—Fluorouracil—colon cancer	0.00345	0.00345	CcSEcCtD
Diatrizoate—Haemorrhage—Fluorouracil—colon cancer	0.00345	0.00345	CcSEcCtD
Diatrizoate—Hypoaesthesia—Fluorouracil—colon cancer	0.00343	0.00343	CcSEcCtD
Diatrizoate—Skin exfoliation—Methotrexate—colon cancer	0.00341	0.00341	CcSEcCtD
Diatrizoate—Face oedema—Capecitabine—colon cancer	0.00336	0.00336	CcSEcCtD
Diatrizoate—Flushing—Irinotecan—colon cancer	0.00334	0.00334	CcSEcCtD
Diatrizoate—Cardiac arrest—Capecitabine—colon cancer	0.00331	0.00331	CcSEcCtD
Diatrizoate—Coma—Methotrexate—colon cancer	0.00326	0.00326	CcSEcCtD
Diatrizoate—Blood creatinine increased—Capecitabine—colon cancer	0.00326	0.00326	CcSEcCtD
Diatrizoate—Chills—Irinotecan—colon cancer	0.00323	0.00323	CcSEcCtD
Diatrizoate—Arrhythmia—Irinotecan—colon cancer	0.00321	0.00321	CcSEcCtD
Diatrizoate—Pulmonary oedema—Methotrexate—colon cancer	0.00318	0.00318	CcSEcCtD
Diatrizoate—Arrhythmia—Fluorouracil—colon cancer	0.00308	0.00308	CcSEcCtD
Diatrizoate—Muscle spasms—Irinotecan—colon cancer	0.00301	0.00301	CcSEcCtD
Diatrizoate—Asthma—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Diatrizoate—Erythema—Fluorouracil—colon cancer	0.003	0.003	CcSEcCtD
Diatrizoate—Thrombophlebitis—Methotrexate—colon cancer	0.00299	0.00299	CcSEcCtD
Diatrizoate—Anaemia—Vincristine—colon cancer	0.00297	0.00297	CcSEcCtD
Diatrizoate—Bronchospasm—Capecitabine—colon cancer	0.00296	0.00296	CcSEcCtD
Diatrizoate—Agitation—Vincristine—colon cancer	0.00296	0.00296	CcSEcCtD
Diatrizoate—Anaemia—Irinotecan—colon cancer	0.00289	0.00289	CcSEcCtD
Diatrizoate—Leukopenia—Vincristine—colon cancer	0.00288	0.00288	CcSEcCtD
Diatrizoate—Neutropenia—Capecitabine—colon cancer	0.00281	0.00281	CcSEcCtD
Diatrizoate—Renal failure acute—Methotrexate—colon cancer	0.00281	0.00281	CcSEcCtD
Diatrizoate—Leukopenia—Irinotecan—colon cancer	0.0028	0.0028	CcSEcCtD
Diatrizoate—Convulsion—Vincristine—colon cancer	0.00279	0.00279	CcSEcCtD
Diatrizoate—Hypertension—Vincristine—colon cancer	0.00278	0.00278	CcSEcCtD
Diatrizoate—Anaemia—Fluorouracil—colon cancer	0.00277	0.00277	CcSEcCtD
Diatrizoate—Loss of consciousness—Irinotecan—colon cancer	0.00275	0.00275	CcSEcCtD
Diatrizoate—Cough—Irinotecan—colon cancer	0.00273	0.00273	CcSEcCtD
Diatrizoate—Hypertension—Irinotecan—colon cancer	0.0027	0.0027	CcSEcCtD
Diatrizoate—Leukopenia—Fluorouracil—colon cancer	0.00269	0.00269	CcSEcCtD
Diatrizoate—Anaphylactoid reaction—Methotrexate—colon cancer	0.00268	0.00268	CcSEcCtD
Diatrizoate—Acute coronary syndrome—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Diatrizoate—Renal failure—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Diatrizoate—Myocardial infarction—Capecitabine—colon cancer	0.00263	0.00263	CcSEcCtD
Diatrizoate—Anaphylactic shock—Vincristine—colon cancer	0.00262	0.00262	CcSEcCtD
Diatrizoate—Oedema—Vincristine—colon cancer	0.00262	0.00262	CcSEcCtD
Diatrizoate—Infection—Vincristine—colon cancer	0.00261	0.00261	CcSEcCtD
Diatrizoate—Conjunctivitis—Capecitabine—colon cancer	0.00261	0.00261	CcSEcCtD
Diatrizoate—Convulsion—Fluorouracil—colon cancer	0.0026	0.0026	CcSEcCtD
Diatrizoate—Confusional state—Irinotecan—colon cancer	0.00258	0.00258	CcSEcCtD
Diatrizoate—Thrombocytopenia—Vincristine—colon cancer	0.00257	0.00257	CcSEcCtD
Diatrizoate—Haematuria—Capecitabine—colon cancer	0.00256	0.00256	CcSEcCtD
Diatrizoate—Oedema—Irinotecan—colon cancer	0.00256	0.00256	CcSEcCtD
Diatrizoate—Anaphylactic shock—Irinotecan—colon cancer	0.00256	0.00256	CcSEcCtD
Diatrizoate—Chest pain—Fluorouracil—colon cancer	0.00255	0.00255	CcSEcCtD
Diatrizoate—Infection—Irinotecan—colon cancer	0.00254	0.00254	CcSEcCtD
Diatrizoate—Hyperhidrosis—Vincristine—colon cancer	0.00254	0.00254	CcSEcCtD
Diatrizoate—Shock—Irinotecan—colon cancer	0.00251	0.00251	CcSEcCtD
Diatrizoate—Thrombocytopenia—Irinotecan—colon cancer	0.0025	0.0025	CcSEcCtD
Diatrizoate—Hyperhidrosis—Irinotecan—colon cancer	0.00247	0.00247	CcSEcCtD
Diatrizoate—Confusional state—Fluorouracil—colon cancer	0.00247	0.00247	CcSEcCtD
Diatrizoate—Hypotension—Vincristine—colon cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Anaphylactic shock—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Oedema—Fluorouracil—colon cancer	0.00245	0.00245	CcSEcCtD
Diatrizoate—Infection—Fluorouracil—colon cancer	0.00243	0.00243	CcSEcCtD
Diatrizoate—Haemoglobin—Capecitabine—colon cancer	0.00242	0.00242	CcSEcCtD
Diatrizoate—Rhinitis—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Diatrizoate—Haemorrhage—Capecitabine—colon cancer	0.00241	0.00241	CcSEcCtD
Diatrizoate—Thrombocytopenia—Fluorouracil—colon cancer	0.0024	0.0024	CcSEcCtD
Diatrizoate—Hypoaesthesia—Capecitabine—colon cancer	0.0024	0.0024	CcSEcCtD
Diatrizoate—Tachycardia—Fluorouracil—colon cancer	0.00239	0.00239	CcSEcCtD
Diatrizoate—Hypotension—Irinotecan—colon cancer	0.00239	0.00239	CcSEcCtD
Diatrizoate—Paraesthesia—Vincristine—colon cancer	0.00236	0.00236	CcSEcCtD
Diatrizoate—Paraesthesia—Irinotecan—colon cancer	0.0023	0.0023	CcSEcCtD
Diatrizoate—Hypotension—Fluorouracil—colon cancer	0.00229	0.00229	CcSEcCtD
Diatrizoate—Dyspnoea—Irinotecan—colon cancer	0.00228	0.00228	CcSEcCtD
Diatrizoate—Pain—Vincristine—colon cancer	0.00224	0.00224	CcSEcCtD
Diatrizoate—Asthma—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Diatrizoate—Flushing—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Diatrizoate—Paraesthesia—Fluorouracil—colon cancer	0.0022	0.0022	CcSEcCtD
Diatrizoate—Pain—Irinotecan—colon cancer	0.00219	0.00219	CcSEcCtD
Diatrizoate—Dyspnoea—Fluorouracil—colon cancer	0.00218	0.00218	CcSEcCtD
Diatrizoate—Chills—Capecitabine—colon cancer	0.00216	0.00216	CcSEcCtD
Diatrizoate—Arrhythmia—Capecitabine—colon cancer	0.00215	0.00215	CcSEcCtD
Diatrizoate—Feeling abnormal—Irinotecan—colon cancer	0.00211	0.00211	CcSEcCtD
Diatrizoate—Erythema—Capecitabine—colon cancer	0.0021	0.0021	CcSEcCtD
Diatrizoate—Neutropenia—Methotrexate—colon cancer	0.00209	0.00209	CcSEcCtD
Diatrizoate—Pain—Fluorouracil—colon cancer	0.00209	0.00209	CcSEcCtD
Diatrizoate—Body temperature increased—Vincristine—colon cancer	0.00207	0.00207	CcSEcCtD
Diatrizoate—Dysgeusia—Capecitabine—colon cancer	0.00205	0.00205	CcSEcCtD
Diatrizoate—Body temperature increased—Irinotecan—colon cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Feeling abnormal—Fluorouracil—colon cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Muscle spasms—Capecitabine—colon cancer	0.00202	0.00202	CcSEcCtD
Diatrizoate—Tremor—Capecitabine—colon cancer	0.00196	0.00196	CcSEcCtD
Diatrizoate—Renal failure—Methotrexate—colon cancer	0.00196	0.00196	CcSEcCtD
Diatrizoate—Urticaria—Fluorouracil—colon cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Conjunctivitis—Methotrexate—colon cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Anaemia—Capecitabine—colon cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Body temperature increased—Fluorouracil—colon cancer	0.00194	0.00194	CcSEcCtD
Diatrizoate—Sweating—Methotrexate—colon cancer	0.00191	0.00191	CcSEcCtD
Diatrizoate—Haematuria—Methotrexate—colon cancer	0.0019	0.0019	CcSEcCtD
Diatrizoate—Asthenia—Vincristine—colon cancer	0.00188	0.00188	CcSEcCtD
Diatrizoate—Leukopenia—Capecitabine—colon cancer	0.00188	0.00188	CcSEcCtD
Diatrizoate—Loss of consciousness—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Diatrizoate—Asthenia—Irinotecan—colon cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Cough—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Diatrizoate—Hypertension—Capecitabine—colon cancer	0.00181	0.00181	CcSEcCtD
Diatrizoate—Haemoglobin—Methotrexate—colon cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Diarrhoea—Vincristine—colon cancer	0.0018	0.0018	CcSEcCtD
Diatrizoate—Haemorrhage—Methotrexate—colon cancer	0.00179	0.00179	CcSEcCtD
Diatrizoate—Chest pain—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Diatrizoate—Diarrhoea—Irinotecan—colon cancer	0.00175	0.00175	CcSEcCtD
Diatrizoate—Dizziness—Vincristine—colon cancer	0.00174	0.00174	CcSEcCtD
Diatrizoate—Pruritus—Fluorouracil—colon cancer	0.00173	0.00173	CcSEcCtD
Diatrizoate—Confusional state—Capecitabine—colon cancer	0.00172	0.00172	CcSEcCtD
Diatrizoate—Oedema—Capecitabine—colon cancer	0.00171	0.00171	CcSEcCtD
Diatrizoate—Infection—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Diatrizoate—Dizziness—Irinotecan—colon cancer	0.00169	0.00169	CcSEcCtD
Diatrizoate—Shock—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Diarrhoea—Fluorouracil—colon cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Thrombocytopenia—Capecitabine—colon cancer	0.00168	0.00168	CcSEcCtD
Diatrizoate—Tachycardia—Capecitabine—colon cancer	0.00167	0.00167	CcSEcCtD
Diatrizoate—Vomiting—Vincristine—colon cancer	0.00167	0.00167	CcSEcCtD
Diatrizoate—Rash—Vincristine—colon cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Hyperhidrosis—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Dermatitis—Vincristine—colon cancer	0.00165	0.00165	CcSEcCtD
Diatrizoate—Headache—Vincristine—colon cancer	0.00164	0.00164	CcSEcCtD
Diatrizoate—Vomiting—Irinotecan—colon cancer	0.00163	0.00163	CcSEcCtD
Diatrizoate—Dizziness—Fluorouracil—colon cancer	0.00162	0.00162	CcSEcCtD
Diatrizoate—Rash—Irinotecan—colon cancer	0.00161	0.00161	CcSEcCtD
Diatrizoate—Dermatitis—Irinotecan—colon cancer	0.00161	0.00161	CcSEcCtD
Diatrizoate—Chills—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Diatrizoate—Headache—Irinotecan—colon cancer	0.0016	0.0016	CcSEcCtD
Diatrizoate—Hypotension—Capecitabine—colon cancer	0.0016	0.0016	CcSEcCtD
Diatrizoate—Erythema—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Nausea—Vincristine—colon cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Vomiting—Fluorouracil—colon cancer	0.00156	0.00156	CcSEcCtD
Diatrizoate—Rash—Fluorouracil—colon cancer	0.00154	0.00154	CcSEcCtD
Diatrizoate—Dermatitis—Fluorouracil—colon cancer	0.00154	0.00154	CcSEcCtD
Diatrizoate—Paraesthesia—Capecitabine—colon cancer	0.00154	0.00154	CcSEcCtD
Diatrizoate—Headache—Fluorouracil—colon cancer	0.00153	0.00153	CcSEcCtD
Diatrizoate—Dysgeusia—Methotrexate—colon cancer	0.00153	0.00153	CcSEcCtD
Diatrizoate—Dyspnoea—Capecitabine—colon cancer	0.00153	0.00153	CcSEcCtD
Diatrizoate—Nausea—Irinotecan—colon cancer	0.00152	0.00152	CcSEcCtD
Diatrizoate—Pain—Capecitabine—colon cancer	0.00146	0.00146	CcSEcCtD
Diatrizoate—Nausea—Fluorouracil—colon cancer	0.00145	0.00145	CcSEcCtD
Diatrizoate—Anaemia—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Diatrizoate—Feeling abnormal—Capecitabine—colon cancer	0.00141	0.00141	CcSEcCtD
Diatrizoate—Leukopenia—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Diatrizoate—Cough—Methotrexate—colon cancer	0.00136	0.00136	CcSEcCtD
Diatrizoate—Urticaria—Capecitabine—colon cancer	0.00136	0.00136	CcSEcCtD
Diatrizoate—Body temperature increased—Capecitabine—colon cancer	0.00135	0.00135	CcSEcCtD
Diatrizoate—Convulsion—Methotrexate—colon cancer	0.00135	0.00135	CcSEcCtD
Diatrizoate—Chest pain—Methotrexate—colon cancer	0.00133	0.00133	CcSEcCtD
Diatrizoate—Confusional state—Methotrexate—colon cancer	0.00128	0.00128	CcSEcCtD
Diatrizoate—Anaphylactic shock—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Infection—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Diatrizoate—Thrombocytopenia—Methotrexate—colon cancer	0.00125	0.00125	CcSEcCtD
Diatrizoate—Hyperhidrosis—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Diatrizoate—Asthenia—Capecitabine—colon cancer	0.00123	0.00123	CcSEcCtD
Diatrizoate—Pruritus—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Diatrizoate—Hypotension—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Diatrizoate—Diarrhoea—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Diatrizoate—Paraesthesia—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Dyspnoea—Methotrexate—colon cancer	0.00114	0.00114	CcSEcCtD
Diatrizoate—Dizziness—Capecitabine—colon cancer	0.00113	0.00113	CcSEcCtD
Diatrizoate—Pain—Methotrexate—colon cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Vomiting—Capecitabine—colon cancer	0.00109	0.00109	CcSEcCtD
Diatrizoate—Rash—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Diatrizoate—Dermatitis—Capecitabine—colon cancer	0.00108	0.00108	CcSEcCtD
Diatrizoate—Headache—Capecitabine—colon cancer	0.00107	0.00107	CcSEcCtD
Diatrizoate—Feeling abnormal—Methotrexate—colon cancer	0.00105	0.00105	CcSEcCtD
Diatrizoate—Nausea—Capecitabine—colon cancer	0.00102	0.00102	CcSEcCtD
Diatrizoate—Urticaria—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Diatrizoate—Body temperature increased—Methotrexate—colon cancer	0.00101	0.00101	CcSEcCtD
Diatrizoate—Asthenia—Methotrexate—colon cancer	0.000914	0.000914	CcSEcCtD
Diatrizoate—Pruritus—Methotrexate—colon cancer	0.000901	0.000901	CcSEcCtD
Diatrizoate—Diarrhoea—Methotrexate—colon cancer	0.000871	0.000871	CcSEcCtD
Diatrizoate—Dizziness—Methotrexate—colon cancer	0.000842	0.000842	CcSEcCtD
Diatrizoate—Vomiting—Methotrexate—colon cancer	0.00081	0.00081	CcSEcCtD
Diatrizoate—Rash—Methotrexate—colon cancer	0.000803	0.000803	CcSEcCtD
Diatrizoate—Dermatitis—Methotrexate—colon cancer	0.000802	0.000802	CcSEcCtD
Diatrizoate—Headache—Methotrexate—colon cancer	0.000798	0.000798	CcSEcCtD
Diatrizoate—Nausea—Methotrexate—colon cancer	0.000756	0.000756	CcSEcCtD
